American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$374M |
| 2 |
Meta Platforms (Facebook)
META
|
+$255M |
| 3 |
Salesforce
CRM
|
+$200M |
| 4 |
Target
TGT
|
+$132M |
| 5 |
Reinsurance Group of America
RGA
|
+$124M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$322M |
| 2 |
Visa
V
|
+$240M |
| 3 |
T-Mobile US
TMUS
|
+$229M |
| 4 |
MSCI
MSCI
|
+$209M |
| 5 |
IQVIA
IQV
|
+$209M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.35% |
| 2 | Healthcare | 13.84% |
| 3 | Financials | 13.35% |
| 4 | Consumer Discretionary | 11.5% |
| 5 | Industrials | 10.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RDUS
1026
DELISTED
Radius Recycling
RDUS
| $10.6M | 0.01% |
354,393
+47,920
| +16% | +$1.44M |
|
1027
NBT Bancorp
NBTB
$2.79B
| $10.6M | 0.01% |
333,178
+10,390
| +3% | +$348K |
|
1028
Pultegroup
PHM
$24.8B
| $10.6M | 0.01% |
136,340
+61,528
| +82% | +$4.17M |
|
|
NEWR
1029
DELISTED
New Relic, Inc.
NEWR
| $10.6M | 0.01% |
+161,299
| New | +$11.6M |
|
1030
Innoviva
INVA
$1.53B
| $10.5M | 0.01% |
824,921
-26,256
| -3% | -$329K |
|
1031
ZTO Express
ZTO
$17.4B
| $10.5M | 0.01% |
418,543
+49,230
| +13% | +$1.36M |
|
|
SAGE
1032
DELISTED
Sage Therapeutics
SAGE
| $10.5M | 0.01% |
222,793
+14,231
| +7% | +$708K |
|
1033
Banco Bilbao Vizcaya Argentaria
BBVA
$158B
| $10.5M | 0.01% |
1,361,171
+210,382
| +18% | +$1.5M |
|
1034
Banco Santander
SAN
$211B
| $10.4M | 0.01% |
2,815,558
+446,970
| +19% | +$1.58M |
|
1035
Quanex
NX
$962M
| $10.4M | 0.01% |
388,640
+45,450
| +13% | +$1.01M |
|
1036
Scotiabank
BNS
$112B
| $10.4M | 0.01% |
208,245
+23,524
| +13% | +$1.17M |
|
1037
Avantis International Large Cap Value ETF
AVIV
$2.06B
| $10.3M | 0.01% |
211,765
+47,066
| +29% | +$2.29M |
|
1038
Crown Castle
CCI
$32.3B
| $10.3M | 0.01% |
90,366
-52,057
| -37% | -$6.2M |
|
1039
Intellia Therapeutics
NTLA
$1.67B
| $10.3M | 0.01% |
252,350
-98,145
| -28% | -$3.98M |
|
1040
White Mountains Insurance
WTM
$5.1B
| $10.2M | 0.01% |
7,349
+1,396
| +23% | +$1.97M |
|
1041
Helmerich & Payne
HP
$4.42B
| $10.1M | 0.01% |
285,835
+166,245
| +139% | +$5.67M |
|
1042
ProPetro Holding
PUMP
$1.49B
| $10.1M | 0.01% |
1,224,043
+103,436
| +9% | +$759K |
|
1043
Fulgent Genetics
FLGT
$511M
| $10.1M | 0.01% |
272,271
-6,081
| -2% | -$212K |
|
1044
Leonardo DRS
DRS
$12.2B
| $10.1M | 0.01% |
580,372
-855,023
| -60% | -$13.2M |
|
1045
Ceco Environmental
CECO
$4.66B
| $10M | 0.01% |
751,830
+15,760
| +2% | +$196K |
|
|
VTLE
1046
DELISTED
Vital Energy
VTLE
| $10M | 0.01% |
222,138
+23,553
| +12% | +$1.06M |
|
|
CPRX
1047
DELISTED
Catalyst Pharmaceutical
CPRX
| $10M | 0.01% |
745,781
-66,425
| -8% | -$956K |
|
1048
Royal Caribbean
RCL
$81.6B
| $9.9M | 0.01% |
95,473
+72,959
| +324% | +$5.72M |
|
1049
ZIM Integrated Shipping Services
ZIM
$3.39B
| $9.9M | 0.01% |
799,014
+236,931
| +42% | +$3.81M |
|
1050
Doximity
DOCS
$4.42B
| $9.85M | 0.01% |
289,634
+241,763
| +505% | +$8.05M |
|
Similar funds
American Century Companies's Q2 2023 Portfolio in Review
As of Q2 2023, American Century Companies held 2,884 positions worth $133B, up 4.5% from $127B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
American Century Companies's Q2 2023 filing shows 216 new, 1,601 increased, 807 reduced and 96 closed positions. Its largest new stake was Kenvue: 2,518,495 shares worth $66.5M. The largest sale was Microsoft, an estimated $322M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- American Century Companies's largest Q2 2023 buy was Kenvue: 2,518,495 shares worth $66.5M.
- American Century Companies added most to Becton Dickinson in Q2 2023, an estimated $374M increase.
- American Century Companies's biggest Q2 2023 reduction was Microsoft, cutting an estimated $322M.
- American Century Companies fully exited Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6.00% Mandatory Convertible Preferred Stock, Series B in Q2 2023, selling an estimated $199M.
- American Century Companies's ten largest holdings make up 22% of its $133B portfolio in Q2 2023.
- American Century Companies opened 216 new positions and closed 96 in Q2 2023.
- American Century Companies's portfolio value rose 4.5% quarter-over-quarter to $133B.
Based on American Century Companies's 13F filing for Q2 2023, filed 14 Aug 2023.